drugset / Trial / NCT04694300

OTC Naproxen and Acetaminophen Anti-Inflammatory Action in Dental Implant Patients

NCT04694300

RandomizedParallel-groupQuadruple-blindBasic science

Summary

This double-blind pilot study will evaluate the anti-inflammatory and analgesic effects of an over-the-counter (OTC) regimen of naproxen sodium versus acetaminophen in patients receiving one or two (adjacent) dental implants. It will also confirm that naproxen sodium in the OTC dosage range is a good alternative to immediate-release opioid formulations, which are subject to misuse, abuse and diversion in this patient population.

Timeline

Start
2021-02-07
Primary completion
2022-08-28
Completion
2022-08-28

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 1000 mg Oral
Subject Naproxen Small molecule 220 mg Oral
Background Tramadol Other / unclassified 50 mg

Indications

No indication recorded.